Cargando…

Standard and reference‐based conditional mean imputation

Clinical trials with longitudinal outcomes typically include missing data due to missed assessments or structural missingness of outcomes after intercurrent events handled with a hypothetical strategy. Approaches based on Bayesian random multiple imputation and Rubin's rules for pooling results...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolbers, Marcel, Noci, Alessandro, Delmar, Paul, Gower‐Page, Craig, Yiu, Sean, Bartlett, Jonathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Main Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790242/ https://www.ncbi.nlm.nih.gov/pubmed/35587109 http://dx.doi.org/10.1002/pst.2234

Ejemplares similares

Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results
por: Kayembe, Mutamba T., et al.
Publicado: (2020)

Reference‐based sensitivity analysis for time‐to‐event data
por: Atkinson, Andrew, et al.
Publicado: (2019)

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
por: Austin, Peter C
Publicado: (2011)

Should the two‐trial paradigm still be the gold standard in drug assessment?
por: Zhan, Stella Jinran, et al.
Publicado: (2022)

Estimating survival parameters under conditionally independent left truncation
por: Sondhi, Arjun
Publicado: (2022)

Conditional assurance: the answer to the questions that should be asked within drug development
por: Temple, Jane R., et al.
Publicado: (2021)

A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods
por: Bennett, Maxine, et al.
Publicado: (2021)

Burden‐of‐illness vaccine efficacy
por: Callegaro, Andrea, et al.
Publicado: (2020)

A compassionate imagery intervention for patients with persecutory delusions
por: Forkert, Ava, et al.
Publicado: (2022)

Cognitive appraisals of dissociation in psychosis: a new brief measure
por: Černis, Emma, et al.
Publicado: (2021)

Are young people with primary social anxiety disorder less likely to recover following generic CBT compared to young people with other primary anxiety disorders? A systematic review and meta-analysis
por: Evans, Rachel, et al.
Publicado: (2021)

Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)
por: Rosebrock, Laina, et al.
Publicado: (2022)

STW 5 (Iberogast(®))—a safe and effective standard in the treatment of functional gastrointestinal disorders
por: Ottillinger, Bertram, et al.
Publicado: (2012)

Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation
por: Patel, K B, et al.
Publicado: (2023)

Assessment of machine perfusion conditions for the donation after circulatory death heart preservation
por: Cholyway, Renee, et al.
Publicado: (2022)

Escalation strategies for combination therapy Phase I trials
por: Sweeting, Michael J, et al.
Publicado: (2012)

A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials
por: Bowden, J, et al.
Publicado: (2014)

Do single‐arm trials have a role in drug development plans incorporating randomised trials?
por: Grayling, Michael J., et al.
Publicado: (2015)

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014)

Optimal composite scores for longitudinal clinical trials under the linear mixed effects model
por: Ard, M. Colin, et al.
Publicado: (2015)

Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims
por: Jaki, Thomas, et al.
Publicado: (2016)

Response‐adaptive designs for binary responses: How to offer patient benefit while being robust to time trends?
por: Villar, Sofía S., et al.
Publicado: (2017)

A proposal for a new PhD level curriculum on quantitative methods for drug development
por: Jaki, T., et al.
Publicado: (2018)

Dose‐escalation strategies which use subgroup information
por: Cotterill, Amy, et al.
Publicado: (2018)

Blinded continuous monitoring in clinical trials with recurrent event endpoints
por: Friede, Tim, et al.
Publicado: (2018)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Α Markov model for longitudinal studies with incomplete dichotomous outcomes
por: Efthimiou, Orestis, et al.
Publicado: (2016)

Misspecification of at‐risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
por: Law, M., et al.
Publicado: (2016)

An optimal stratified Simon two‐stage design
por: Parashar, Deepak, et al.
Publicado: (2016)

Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols
por: Häckl, Sebastian, et al.
Publicado: (2019)

A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
por: Huber, Cynthia, et al.
Publicado: (2019)

Prior distributions for variance parameters in a sparse‐event meta‐analysis of a few small trials
por: Pateras, Konstantinos, et al.
Publicado: (2020)

Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology
por: Ristl, Robin, et al.
Publicado: (2020)

Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study
por: Lasch, Florian, et al.
Publicado: (2021)

A robust permutation test for the concordance correlation coefficient
por: Hutson, Alan D., et al.
Publicado: (2021)

A comparison of reweighting estimators of average treatment effects in real world populations
por: Lin, Chen‐Yen, et al.
Publicado: (2021)

Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile
por: Matsuura, Kentaro, et al.
Publicado: (2021)

A critical review of graphics for subgroup analyses in clinical trials
por: Ballarini, Nicolás M., et al.
Publicado: (2020)

Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing
por: Best, Nicky, et al.
Publicado: (2021)

A confidence function‐based posterior probability design for phase II cancer trials
por: Shan, Minghua
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mq5g59s43mlaiqp552jr2h8b96